-
Selection of Methods for Percutaneous Endoscopic Gastrostomy (PEG) that is more Safety and Useful Techniques on the Patients
Ken Kawaura, Tohru Itoh, Kazu Hamada, Hidekazu Kitakata, Sadahumi Azukisawa, Hideyuki Okamura, Sachio Urashima, Masaru Sakurai, Masao Ishizaki
Research Article: Clinical Investigation
-
Selection of Methods for Percutaneous Endoscopic Gastrostomy (PEG) that is more Safety and Useful Techniques on the Patients
Ken Kawaura, Tohru Itoh, Kazu Hamada, Hidekazu Kitakata, Sadahumi Azukisawa, Hideyuki Okamura, Sachio Urashima, Masaru Sakurai, Masao Ishizaki
Research Article: Clinical Investigation
-
Selection of Methods for Percutaneous Endoscopic Gastrostomy (PEG) that is more Safety and Useful Techniques on the Patients
Ken Kawaura, Tohru Itoh, Kazu Hamada, Hidekazu Kitakata, Sadahumi Azukisawa, Hideyuki Okamura, Sachio Urashima, Masaru Sakurai, Masao Ishizaki
Research Article: Clinical Investigation
-
Selection of Methods for Percutaneous Endoscopic Gastrostomy (PEG) that is more Safety and Useful Techniques on the Patients
Ken Kawaura, Tohru Itoh, Kazu Hamada, Hidekazu Kitakata, Sadahumi Azukisawa, Hideyuki Okamura, Sachio Urashima, Masaru Sakurai, Masao Ishizaki
Research Article: Clinical Investigation
-
Selection of Methods for Percutaneous Endoscopic Gastrostomy (PEG) that is more Safety and Useful Techniques on the Patients
Ken Kawaura, Tohru Itoh, Kazu Hamada, Hidekazu Kitakata, Sadahumi Azukisawa, Hideyuki Okamura, Sachio Urashima, Masaru Sakurai, Masao Ishizaki
Research Article: Clinical Investigation
-
Selection of Methods for Percutaneous Endoscopic Gastrostomy (PEG) that is more Safety and Useful Techniques on the Patients
Ken Kawaura, Tohru Itoh, Kazu Hamada, Hidekazu Kitakata, Sadahumi Azukisawa, Hideyuki Okamura, Sachio Urashima, Masaru Sakurai, Masao Ishizaki
Research Article: Clinical Investigation
-
Selection of Methods for Percutaneous Endoscopic Gastrostomy (PEG) that is more Safety and Useful Techniques on the Patients
Ken Kawaura, Tohru Itoh, Kazu Hamada, Hidekazu Kitakata, Sadahumi Azukisawa, Hideyuki Okamura, Sachio Urashima, Masaru Sakurai, Masao Ishizaki
Research Article: Clinical Investigation
-
Selection of Methods for Percutaneous Endoscopic Gastrostomy (PEG) that is more Safety and Useful Techniques on the Patients
Ken Kawaura, Tohru Itoh, Kazu Hamada, Hidekazu Kitakata, Sadahumi Azukisawa, Hideyuki Okamura, Sachio Urashima, Masaru Sakurai, Masao Ishizaki
Research Article: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Parathyroid hormone replacement in hypoparathyroidism
Sharon H Chou & Tamara Vokes
Clinical Trail Outcomes: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Does enrollment in a trial carry a survival advantage for patients?
Tal Shahar, Uri Rozovski, Zvi Ram
Editorial: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Clinical evidence for the role of pixantrone in the treatment of relapsed or refractory aggressive non-Hodgkins lymphoma
Anne W Beaven , David Rizzieri
Review: Clinical Trail Outcomes: Clinical Investigation
-
Maintenance treatment of multiple myeloma: evidence from recent clinical trials
Donna E Reece
Review Article: Clinical Investigation
-
Maintenance treatment of multiple myeloma: evidence from recent clinical trials
Donna E Reece
Review Article: Clinical Investigation
-
Maintenance treatment of multiple myeloma: evidence from recent clinical trials
Donna E Reece
Review Article: Clinical Investigation
-
Maintenance treatment of multiple myeloma: evidence from recent clinical trials
Donna E Reece
Review Article: Clinical Investigation
-
Maintenance treatment of multiple myeloma: evidence from recent clinical trials
Donna E Reece
Review Article: Clinical Investigation
-
Maintenance treatment of multiple myeloma: evidence from recent clinical trials
Donna E Reece
Review Article: Clinical Investigation
-
Maintenance treatment of multiple myeloma: evidence from recent clinical trials
Donna E Reece
Review Article: Clinical Investigation
-
Maintenance treatment of multiple myeloma: evidence from recent clinical trials
Donna E Reece
Review Article: Clinical Investigation